Axon Enterprise Stock Jumps After Earnings. Tasers Are Going International. -- Barrons.com

Dow Jones
05/08

By Nate Wolf

Shares of Axon Enterprise rose sharply Thursday after the maker of law-enforcement technology like Tasers and body cameras reported a spike in international sales.

The company posted adjusted earnings of $1.61 a share for the first quarter, up from $1.41 last year. Analysts had anticipated $1.60, according to FactSet. Operating income came in at $29 million after five consecutive quarters of losses.

Revenue grew 34% from last year to $807.3 million, above Wall Street's call for $778.9 million. Non-U.S. revenue spiked to $160.8 million from $74.3 million a year ago. Management now expects full-year revenue growth of 31% at the midpoint, up from a prior forecast of 28.5%

Axon stock jumped 7.6% to $415.14 on Thursday. Shares remain down 27% this year and 40% over the last 12 months. Fears about disruption by artificial intelligence and the company's consistent operating losses have driven the decline.

The company has tried to assuage those concerns, using computer vision models in cameras and integrating AI into its communications and camera software. Revenue from AI products grew more than 700% year over year in the first quarter, though the company was starting from a low base.

International growth was another bright spot. Non-U.S. business now accounts for around one-fifth of the company's total revenue, up from 12% a year ago.

"I just think we're showing up as more of a global company at this point, " President Josh Isner said on a conference call. "It's not, you know, one person in a very large country showing up trying to sell Tasers for the first time. We're showing up like a technology vendor that can help across a number of different product lines."

While the results and guidance were positive, UBS analyst Andrew Spinola was skeptical that a single earnings report could overcome the broader concerns around the stock. The firm maintained a Neutral rating on Axon shares and slashed its price target to $440 from $570, reflecting its falling valuation.

"We don't think this will be enough to offset concerns about the company's FCF generation and general concerns about AI disruption," Spinola wrote in a research note.

Write to Nate Wolf at nate.wolf@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

May 07, 2026 12:02 ET (16:02 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10